[Sensitivity to acetylsalicylic acid]

Area of Science:

• Pharmacology
• Immunology
• Otolaryngology

Context:

• Rising aspirin consumption in Norway linked to anti-platelet properties.
• Aspirin sensitivity is a growing concern, affecting individuals with conditions like chronic rhinosinusitis, nasal polyposis, and asthma.
• Cross-reactivity with non-steroidal anti-inflammatory drugs (NSAIDs), azo-dyes, and food preservatives can trigger airway inflammation.

Purpose:

• To review the current understanding of aspirin sensitivity.
• To discuss the biochemical mechanisms underlying aspirin sensitivity.
• To explore potential future treatments, including desensitization and leukotriene receptor antagonists.

Summary:

• Aspirin's anti-platelet aggregation properties are driving increased use in Norway.
• Aspirin sensitivity is associated with specific respiratory conditions and can be triggered by NSAIDs and certain food additives.
• The underlying biochemical pathways of aspirin sensitivity remain unclear.
• Future therapeutic strategies may involve desensitization protocols and novel drug development.

Impact:

• Highlights the need for monitoring long-term, low-dose aspirin use for potential benefits and adverse effects on aspirin sensitivity.
• Suggests promising avenues for future research and clinical interventions in managing aspirin-sensitive individuals.
• Emphasizes the importance of understanding cross-reactivity with other substances.